A world famous British teaching hospital is testing new complementary medical protocols which have improved quality of life and survival rates for cancer sufferers in Switzerland.

Barts Hospital has already selected the first of an initial 10 prostate patients to receive the therapy and, if successful, the programme will be broadened considerably. The case studies are being undertaken by Professor Tim Oliver, Head of Oncology.

The move follows five years of research using complementary therapy, published in the Swiss Journal of Urology, January 2005.

The pioneer is Professor Dr Ben Pfeifer, Director for Clinical Research at the renowned Aeskulap Clinic in Switzerland, a specialist in cancers including breast, lung and prostate. He works daily with a range of international patients, and in the published trials used phytonutrients and other natural compounds to achieve results among men with prostate cancer which demonstrated improved efficacy of treatment programmes, reduction in side effects, and a boost of immune function activity which destroyed cancer cells.

More than two thirds of patients experienced a fall in PSA levels of more than 50 per cent. One, with a PSA approaching 1000, and scarred lungs, is now living a fully active life, with a PSA reading which is unmeasurable.

The professor, an immunologist, believes that, in time, such protocols could be routinely used on a wide range of illnesses in which the body's immune system plays a major role.

At the heart of the protocol is BioBran, a natural supplement made by breaking down rice bran using enzymes from an immune-boosting extract found in Shitake mushrooms. The resulting compound contains a unique blend of glyconutrients such as Arabinoxylan and has been shown to be one of the most effective natural immune system supplements available today.

BioBran works by boosting the activity of the immune system's natural killer cells. These form the front line of defence against infected or abnormal blood cells. Tests (1) show that it not only stimulates natural killer cell activity by more than 300%, it also increases T cell and B cell activity by 250% and 200% respectively and it is this optimisation of the immune system function that helps the body destroy cancer cells.

About the MURRAY PR

MurrayPr is a thriving, specialists hand-on consultancy with a passion for media coverage, backed by strong ideas and direction.

MURRAY PR
26-27 West Street
Horsham
West Sussex

murraypr